FindTrial
Sign In

Fatty Acid Binding Protein 4 in subjects with diabetes and peripheral arterial disease

Interplay between Fatty Acid Binding Protein 4 (FABP4) and Peripheral Arterial Disease in Type 2 diabetes in Indian population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/047992
Enrollment
110
Registered
2022-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

Intervention1: NIL: NIL

Sponsors

Medical Research Unit of IPGMER Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Type 2 Diabetes Mellitus according to ADA (American diabetes association criteria) with or without peripheral arterial disease and age-gender matched controls

Exclusion criteria

Exclusion criteria: 1. Type 1 DM 3. Pregnancy 4. Recent major cardiovascular events in last 3 months 5. Subjects with stage 3b to stage 5 kidney disease 6. Chronic Infections (HIV, Hepatitis etc.) 7. Chronic inflammatory disease 8. Malignancy 9. Patients receiving immunosuppressive agents 10. Patients with active covid infection 11. Patients with organ failure

Design outcomes

Primary

MeasureTime frame
FABP4 level in PAD patientsTimepoint: No specific time points since it is a cross-sectional study—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactPranab Kumar Sahana

Institute of Post Graduate Medical Education and Research and SSKMH

pranabsahana@gmail.com9231523624

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026